ArticleAddiction (Abingdon, England)2026
Adolescent cannabis use disorder following recreational cannabis legalization in California, USA: A population-based interrupted time series study.
Article in Addiction (Abingdon, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
aimsTo examine whether and how rates of adolescent cannabis use disorder (CUD) in California, USA, changed after recreational cannabis legalization (RCL). DESIGN AND
settingPopulation-based time-series study of adolescents aged 13 to 17 years with Kaiser Permanente Northern California healthcare system membership from January 2014 to February 2020.
participantsThe sample (n = 637 461) was 66.45% non-White, 50.93% male, with a mean (standard deviation) age of 14.07 (1.43) years. MEASUREMENTS: Exposure variables included California state RCL passage (9 November 2016), which legalized possession, home grows and reduced penalties for underage possession; and implementation of legal recreational sales (1 January 2018). Outcome was the count of incident CUD diagnoses in each month, extracted from the electronic health record. Interrupted time series analyses were fit using Poisson regression.
resultsIn the best fitting model, prior to RCL passage, CUD rates were decreasing [adjusted rate ratio (aRR) = 0.95 per year, 95% confidence interval (CI) = 0.92-0.97]. Rates increased at the time of RCL passage + 6-month lag (adjusted slope change aRR = 1.26, 95% CI = 1.14-1.38). At RCL implementation + 6 months, there was a statistically significant negative slope change (adjusted slope change aRR = 0.86, 95% CI = 0.76-0.98). CUD incidence continued to increase, but was no longer statistically significant (adjusted trend aRR = 1.02, 95% CI = 0.96-1.09). SUMMARY: Among adolescents in Northern California, USA, trends in incident cannabis use disorder rates appeared to increase following recreational cannabis legalization passage, with increasing rates persisting through retail implementation and three years post-passage. Results underscore the importance of monitoring cannabis use disorder, in addition to measures of cannabis use prevalence and frequency, when evaluating the public health implications of cannabis legalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.